CHA 3554 Flydende middel Danmark - dansk - SEGES Landbrug & Fødevarer

cha 3554 flydende middel

cheminova a/s - dimethoat, gamma-cyhalothrin - flydende middel - 400 g/l dimethoat; 4 g/l gamma-cyhalothrin

CHA 3556 Flydende middel Danmark - dansk - SEGES Landbrug & Fødevarer

cha 3556 flydende middel

cheminova a/s - dimethoat, gamma-cyhalothrin - flydende middel - 400 g/l dimethoat; 6,4 g/l gamma-cyhalothrin

Perfekthion 500 S Emulsionskoncentrat Danmark - dansk - SEGES Landbrug & Fødevarer

perfekthion 500 s emulsionskoncentrat

basf a/s - dimethoat - emulsionskoncentrat - 500 g/l dimethoat

Danadim Progress Emulsionskoncentrat Danmark - dansk - SEGES Landbrug & Fødevarer

danadim progress emulsionskoncentrat

fmc agricultural solutions a/s (tidligere: cheminova a/s) - dimethoat - emulsionskoncentrat - 400 g/l dimethoat

Dimethyl fumarate Mylan Den Europæiske Union - dansk - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Den Europæiske Union - dansk - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Den Europæiske Union - dansk - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Den Europæiske Union - dansk - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Polpharma Den Europæiske Union - dansk - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.